Please login to the form below

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices. A vision to make a positive impact on the success of our clients, the economy and the wider society.It’s a passion that provides the beating heart of everything we do, and a vision that lives on in our company today, alongside our unwavering values of quality and excellence, as we push the boundaries of our work in market access consulting.The early industry pioneers of market access, are the creative force behind Accession. Today we are a specialist team of market access innovators, go-getters, strategists, scientists, analysts, and economists. We combine our deep industry experience with our knowledge of the changing environment and the drive to innovate. And we do this for one reason, to unlock potential for your brand. Together we can accelerate your innovation process and disrupt the status quo. Your customers and their patients will thank you for it.

Areas of Expertise

Market Access Disruptors and Innovators

Press Releases

Accession announces investment to support next phase of growth

March 2021: Accession Healthcare Consulting (Accession), a specialist pharma market access consultancy, today announces that it has received private investment from a group of highly experienced healthcare and technology investors to support its continued strong performance and ambitious growth plans.

Company Details

Accession

01491 577563

Contact Website

Address:
Accession Healthcare Consulting Ltd
Southfield House
24 Greys Road
Henley on Thames
Oxfordshire
RG9 1RY
United Kingdom

Latest content on this profile

Accession announces investment to support next phase of growth
March 2021: Accession Healthcare Consulting (Accession), a specialist pharma market access consultancy, today announces that it has received private investment from a group of highly experienced healthcare and technology investors to support its continued strong performance and ambitious growth plans.
Accession